Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
Carl Graham(King's College London), Katie J. Doores(King's College London)
Cited by 167
Related Papers
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
|Nature Microbiology|2020|1.4k
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
|bioRxiv (Cold Spring Harbor Laboratory)|2021|33
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
|Cell Reports|2025|6
Cross-reactivity of glycan-reactive HIV-1 broadly neutralizing antibodies with parasite glycans
|Cell Reports|2022|5
Spike-specific IgG4 generated post BNT162b2 mRNA vaccination is inhibitory when directly competing with functional IgG subclasses
|bioRxiv (Cold Spring Harbor Laboratory)|2025|2